Picture courtesy The News Minute
Hyderabad: Pfizer and the Serum Institute of India (SII) had already sought emergency use approval for their COVID-19 vaccines from the Drug Controller General of India (DCGI).
Now, Hyderabad-based Bharat Biotech followed suit in urging the DCGI for the approval for its indigenously made COVID vaccine Covaxin, reported India Today.
Bharat Biotech is indigenously developing Covaxin in association with the Indian Council of Medical Research (ICMR).
The Phase 3 trials of the respective vaccine candidates of both SII and Bharat Biotech are currently being conducted in India.
New Delhi: After the record-breaking success of ‘Pushpa 2: The Rule’, Rashmika Mandanna has her…
Bhubaneswar: Twelve members of Village Water and Sanitation Committees (VWSC) from nine districts of Odisha…
Hyderabad: Bollywood actress Janhvi Kapoor, who is rumoured to be dating Shikhar Pahariya, had once…
Bhubaneswar: In a remarkable stride toward strengthening industrial ecosystem, the Odisha government on Wednesday approved…
Bengaluru: Playing away from home, Odisha FC turned the game on its head to snatch a…
Hyderabad: Two weeks after its Telugu release, the Hindi version of Balakrishna-Urvashi Rautela starrer ‘Daaku…
This website uses cookies.
